Open Payments CMS Addresses Open Payments Data Submission Problems Thomas Sullivan Aug 21, 2014 0 Yesterday, CMS addressed why many records have been deleted from Open Payments. As we wrote, many of the problems are tied…
Open Payments Physician Payments Sunshine Act: Manufacturers See Their Submitted Open… Thomas Sullivan Aug 20, 2014 1 This week, scores of executives from pharmaceutical and device companies gathered in Washington, DC for CBI’s Eighth Annual…
Medical Legal D.C. Circuit Court Reaffirms Attorney-Client Privilege in Internal… Thomas Sullivan Aug 20, 2014 0 As reported by the law firm Husch Blackwell, a recent D.C. Circuit court decision reaffirms that the attorney-client privilege…
Open Payments CMS’ Ambiguous Open Payments Timeline Thomas Sullivan Aug 19, 2014 0 This article examines the shifting timeline for Open Payments registration, the dispute resolution process, and as of August 15,…
Open Payments Physician Payments Sunshine Act: CMS Will Withhold A Large Amount of… Thomas Sullivan Aug 18, 2014 0 In just over a month, on September 30th, the Centers for Medicare and Medicaid Services (CMS) is scheduled to publish a searchable…
FDA FDA ANDA Submissions Content and Format of Abbreviated New Drug… Thomas Sullivan Aug 18, 2014 0 Recently, the US Food and Drug Administration (FDA) released a new draft guidance document on the content and format of…
Open Payments Physician Payments Sunshine Act: CMS Extends Dispute Window to September 8;… Thomas Sullivan Aug 15, 2014 0 As an update on our continuing coverage of the Open Payments website and physician dispute resolution process, the Centers for…
Open Payments Physician Payments Sunshine Act: Open Payments System Back Up After 11 Days… Thomas Sullivan Aug 15, 2014 0 August 14, 2014: The Centers for Medicare and Medicaid Services (CMS) have fixed the technical problems that caused Open…
Electronic Health Records Health IT Update Summer 2014 Thomas Sullivan Aug 15, 2014 0 We have written previously about the "Meaningful Use" electronic health record (EHR) initiative, which is run by the…
FDA Celgene Faces Off-Label Promotion Lawsuit Over Successful Cancer Drugs… Thomas Sullivan Aug 14, 2014 0 Since 2006, Celgene Corporation has earned $20.9 billion from the sales of two of its drugs—Thalomid and Revlimid. The drugs are…